Thomas Westergard
Impact in
- Neurology top 2%
- Amyotrophic Lateral Sclerosis Research
- Neuroinflammation and Neurodegeneration Mechanisms
-
- Genetic Neurodegenerative Diseases
- Neuroscience and Neuropharmacology Research
Papers in
-
- Amyotrophic Lateral Sclerosis Research 6
- Neuroinflammation and Neurodegeneration Mechanisms 1
-
- Neuroscience and Neuropharmacology Research 3
- Co-authors
- Piera Pasinelli (5 shared papers)Xinmei Wen (5 shared papers)Davide Trotti (5 shared papers)Karthik Krishnamurthy (2 shared papers)Jeffrey D. Rothstein (1 shared paper)Shashirekha S. Markandaiah (1 shared paper)Udai Bhan Pandey (1 shared paper)Wenzhi Tan (1 shared paper)
- Journals
- EMBO Molecular Medicine (2 papers)Biophysical Journal (1 paper)PLoS ONE (1 paper)Neuron (1 paper)Neurochemical Research (1 paper)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Thomas Westergard
9 papers receiving 867 citations
Thomas Westergard's Hit Papers
Peers
Comparison fields: 5 of 38
- Neurology 614
- Cellular and Molecular Neuroscience 90
- Neurology 33
- Molecular Biology 182
- Developmental Neuroscience 8
Countries citing papers authored by Thomas Westergard
This map shows the geographic impact of Thomas Westergard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Westergard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Westergard more than expected).
Fields of papers citing papers by Thomas Westergard
This network shows the impact of papers produced by Thomas Westergard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Westergard. The network helps show where Thomas Westergard may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Westergard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Antisense Proline-Arginine RAN Dipeptides Linked to C9ORF72-ALS/FTD Form Toxic Nuclear Aggregates that Initiate In Vitro and In Vivo Neuronal Death Hit paper breakdown → | 2014 | 441 |
| 2 | 2016 | 177 | |
| 3 | 2019 | 93 | |
| 4 | 2020 | 71 | |
| 5 | 2020 | 43 | |
| 6 | 2016 | 37 | |
| 7 | 2015 | 8 | |
| 8 | 2013 | 1 | |
| 9 | Dipeptide Repeat Proteins Associated with C9orf72 ALS/FTD: Understanding How They Are Made and How They Potentiate Disease | 2018 | 1 |
About Thomas Westergard
Thomas Westergard is a scholar working on Neurology, Cellular and Molecular Neuroscience, Neurology, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 9 papers that have together received 872 indexed citations. Recurring topics across this work include Amyotrophic Lateral Sclerosis Research (6 papers), Neuroscience and Neuropharmacology Research (3 papers) and Neuroinflammation and Neurodegeneration Mechanisms (1 paper). The work is most often cited by research in Neurology (614 citations), Cellular and Molecular Neuroscience (90 citations), Neurology (33 citations), Molecular Biology (182 citations) and Developmental Neuroscience (8 citations). Thomas Westergard has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Piera Pasinelli, Xinmei Wen, Davide Trotti, Karthik Krishnamurthy, Jeffrey D. Rothstein, Shashirekha S. Markandaiah, Udai Bhan Pandey, Wenzhi Tan, Yingxiao Shi and Justin K. Ichida. Their work appears in journals such as EMBO Molecular Medicine, Biophysical Journal, PLoS ONE, Neuron and Neurochemical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.